In the future, we plan to study the regulatory effects of chemotherapy on PD‐L1 or other immune checkpoints in various immune cells, to further deepen our understanding of the regulatory role of chemotherapy on the immune microenvironment, and to provide more treatment options for myeloma chemotherapy and immunotherapy. The gene discussed is CD274; the disease is plasma cell myeloma.